跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
易安平 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ambroxol Hydrochloride Solution for Inhalation
Approved
化学药品
Ambroxol Hydrochloride Solution for Inhalation
Hanpoong Pharm.Co., LTD.
🇨🇳 National Medical Products Administration
Approval Date
Jun 8, 2020
Approval ID
7uctI970F35
Company
Hanpoong Pharm.Co., LTD.
Type
化学药品
Approval Details
Approval Id
7uctI970F35
Approval Number
H20190041
Generic Name
吸入用盐酸氨溴索溶液
Generic Name En
Ambroxol Hydrochloride Solution for Inhalation
Brand Name
易安平
Drug Type
化学药品
Dosage Form
吸入制剂
Strength
2ml:15mg
Reg Date
2020-06-08
Expired Date
2024-07-03
Company Name
Hanpoong Pharm.Co., LTD.
Company Address
214，Muha-ro，Paltan-myeon，Hwaseong-si，Gyeonggi-do，Korea
Production Company Name
Hanpoong Pharm.Co., LTD.
Production Company Address
214, Muha-ro, Paltan-myeon, Hwaseong-si, Gyeonggi-do, Korea
Company Detail Path
/organization/hanpoong-pharm-co-ltd
Production Company Detail Path
/organization/hanpoong-pharm-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 8, 2020
Approval ID
7uctI970F35
Type
化学药品
Back to NMPA Approvals
